Oral pantoprazole for acid suppression in the treatment of patients with Zollinger-Ellison syndrome

Canadian Journal of Gastroenterology

Volumn 15, Issue 12, 2001, Pages 795-798

  Désir, Barbara ^a   Poitras, Pierre ^a  

^a UNIVERSITY OF MONTREAL   (Canada)

Author keywords

Endocrine tumour; Gastric acid secretion; Gastro intestinal hormone; Peptic ulcer; Proton pump inhibitor; Regulatory peptide

Indexed keywords

LANSOPRAZOLE; OMEPRAZOLE; PANTOPRAZOLE; PROTON PUMP INHIBITOR;

ABDOMINAL PAIN; ACHLORHYDRIA; ADULT; AGED; ARTICLE; CLINICAL ARTICLE; CONTROLLED STUDY; DIARRHEA; DISEASE CONTROL; DOSE RESPONSE; DRUG EFFECT; FEMALE; HUMAN; MALE; PRIORITY JOURNAL; STOMACH ACID SECRETION; SYMPTOM; ZOLLINGER ELLISON SYNDROME;

EID: 0035715468     PISSN: 08357900     EISSN: None     Source Type: Journal    
DOI: 10.1155/2001/462456     Document Type: Article

References (18)

1. Primary peptic ulcerations of the jejunum associated with islet-cell tumors of the pancreas
2. Management of patients with Zollinger-Ellison syndrome
3. Omeprazole: Effective, convenient therapy for Zollinger-Ellison syndrome
4. Effects of long term omeprazole on gastric acid secretion and mucosal histology in patients with Zollinger-Ellison syndrome
5. Intravenous pantoprazole rapidly controls gastric acid hypersecretion in patients with Zollinger-Ellison syndrome
6. The control of gastric acid hypersecretion in the management of patients with Zollinger-Ellison syndrome
7. Advances in the management of patients with Zollinger-Ellison syndrome
8. Stricture and perforation of the esophagus: Overlooked threats in the Zollinger-Ellison syndrome
9. Reflux esophagitis in patients with Zollinger-Ellison syndrome
10. Intestinal water and electrolyte transport in man under the effect of exogenous hormones of the gut and in patients with endocrine tumors of the pancreas
11. Gastrinoma: Advances in localization and treatment
12. Acid suppression: Optimizing therapy for gastroduodenal ulcer healing, gastroesophageal reflux disease, and stress-related erosive syndrome
13. Reliability of symptoms in assessing control of gastric acid secretion in patients with Zollinger-Ellison syndrome
14. Management of patients with Zollinger-Ellison syndrome
15. Equipotent inhibition of gastric acid secretion by equal doses of oral or intravenous pantoprazole
16. Evaluation of omeprazole, lansoprazole, pantoprazole and rabeprazole in the treatment of acid-related diseases
17. Efficacious long-term maintenance therapy with pantoprazole in patients with Zollinger-Ellison syndrome